STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (5,679,911)	$ (5,476,018)
Adjustments to reconcile net loss to net cash used in operating activities
Stock options issued for services	626,512	1,795,842
Amortization of deferred compensation	64,199	73,498
Common stock issued for services and fees	76,977	361,694
Depreciation and amortization of patents	386,498	275,276
Amortization of right of use asset	47,011	46,381
Loss on disposal of property and equipment	3,166
(Increase) decrease in assets
Accounts receivable	(26,384)
Prepaid expenses and other current assets	540,932	(91,853)
(Decrease) increase in liabilities
Accounts payable	(447,102)	(427,132)
Accrued bonuses, accrued expenses and other liabilities	(99,381)	(248,151)
Accounts payable and accrued expenses-related parties	(215,886)	(1,367)
Deferred revenue	(4,167)
Deferred lease liability	(10,445)	(10,445)
Operating lease liability	(34,227)	(46,381)
Net cash used in operating activities	(4,772,208)	(3,748,656)
CASH FLOWS FROM INVESTING ACTIVITIES
Cost of intangibles	(53,097)	(106,475)
Purchase of property and equipment	(775,377)	(246,053)
Repayment of loan		642,120
Net cash (used in) provided by investing activities	(828,474)	289,592
CASH FLOWS FROM FINANCING ACTIVITIES
Exercise of options and warrants	194,850	25,750
Issuance of common stock, institutional investor	5,152,350	5,499,377
Common stock sales at the market by investment banking company	330,453
Net cash provided by financing activities	5,677,653	5,525,127
NET INCREASE IN CASH AND CASH EQUIVALENTS	76,971	2,066,063
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	31,432,087	24,102,151
CASH AND CASH EQUIVALENTS - END OF PERIOD	$ 31,509,058	$ 26,168,214